Agenus Inc.
Anti-ILT4 antibodies and antigen-binding fragments

Last updated:

Abstract:

The present invention provides antibodies and antigen-binding fragments thereof that bind to ILT4 (immunoglobulin-like transcript 4) and combinations thereof, e.g., with an anti-PD1 antibody. Also provided are methods of use thereof, for example, for treating or preventing cancer in a subject; and methods of making such antibodies and fragments.

Status:
Grant
Type:

Utility

Filling date:

5 Apr 2018

Issue date:

6 Jul 2021